PTPN11 and myasthenia gravis: Inhibition of SHP-2 using SHP099 completely restored the aberrant pro-migratory phenotype induced by MG, indicating that SHP-2 contributes to monocyte activation in the diabetic milieu (Figure 1G and Figure S1D).